Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

500 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment for postpolio syndrome.
Koopman FS, Uegaki K, Gilhus NE, Beelen A, de Visser M, Nollet F. Koopman FS, et al. Among authors: de visser m. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007818. doi: 10.1002/14651858.CD007818.pub2. Cochrane Database Syst Rev. 2011. PMID: 21328301 Updated. Review.
Treatment for postpolio syndrome.
Koopman FS, Beelen A, Gilhus NE, de Visser M, Nollet F. Koopman FS, et al. Among authors: de visser m. Cochrane Database Syst Rev. 2015 May 18;(5):CD007818. doi: 10.1002/14651858.CD007818.pub3. Cochrane Database Syst Rev. 2015. PMID: 25984923 Review.
Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trial.
Kamperman RG, Bogaards JA, Evers SW, Walter HAW, de Visser M, de Borgie C, Colen-de Koning JCA, Verhamme C, Maas M, Eftimov F, van Schaik IN, van der Kooi AJ, Raaphorst J. Kamperman RG, et al. Among authors: de borgie c, de visser m. BMJ Open. 2023 Jul 10;13(7):e067435. doi: 10.1136/bmjopen-2022-067435. BMJ Open. 2023. PMID: 37429682 Free PMC article.
Ascorbic acid for treatment in CMT1A: what's next?
de Visser M, Verhamme C. de Visser M, et al. Lancet Neurol. 2011 Apr;10(4):291-3. doi: 10.1016/S1474-4422(11)70042-4. Lancet Neurol. 2011. PMID: 21393064 No abstract available.
Disease course and prognostic factors of progressive muscular atrophy.
Visser J, van den Berg-Vos RM, Franssen H, van den Berg LH, Wokke JH, de Jong JM, Holman R, de Haan RJ, de Visser M. Visser J, et al. Among authors: de jong jm, de visser m, de haan rj. Arch Neurol. 2007 Apr;64(4):522-8. doi: 10.1001/archneur.64.4.522. Arch Neurol. 2007. PMID: 17420313
500 results